APA (7th ed.) Citation

Subramaniam, R. M., Shields, A. F., Sachedina, A., Hanna, L., Duan, F., Siegel, B. A., & Hillner, B. E. (2016). Impact on Patient Management of [18F]‐Fluorodeoxyglucose‐Positron Emission Tomography (PET) Used for Cancer Diagnosis: Analysis of Data From the National Oncologic PET Registry. The oncologist (Dayton, Ohio), 21(9), 1079-1084. https://doi.org/10.1634/theoncologist.2015-0364

Chicago Style (17th ed.) Citation

Subramaniam, Rathan M., Anthony F. Shields, Archana Sachedina, Lucy Hanna, Fenghai Duan, Barry A. Siegel, and Bruce E. Hillner. "Impact on Patient Management of [18F]‐Fluorodeoxyglucose‐Positron Emission Tomography (PET) Used for Cancer Diagnosis: Analysis of Data From the National Oncologic PET Registry." The Oncologist (Dayton, Ohio) 21, no. 9 (2016): 1079-1084. https://doi.org/10.1634/theoncologist.2015-0364.

MLA (9th ed.) Citation

Subramaniam, Rathan M., et al. "Impact on Patient Management of [18F]‐Fluorodeoxyglucose‐Positron Emission Tomography (PET) Used for Cancer Diagnosis: Analysis of Data From the National Oncologic PET Registry." The Oncologist (Dayton, Ohio), vol. 21, no. 9, 2016, pp. 1079-1084, https://doi.org/10.1634/theoncologist.2015-0364.